News

News

Emyria Launches Drug Development Program Based on Real-World Evidence

Emyria Launches Drug Development Program Based on Real-World Evidence

Emyria launches drug development program focused on mental health based on analysis of its Real-World Evidence.

Emyria’s Managing Director, Dr Michael Winlo, said: “We’re very enthusiastic about the launch of our own evidence-based drug development program after an extensive review of the IP landscape, published literature and, of course, our own clinical evidence.”

Read full announcement here

Have Questions?

If you have any question, please feel free to get in touch with us.

Call 1300 436 363Contact